Results
VUB spin-off eTheRNA immunotherapies opens office in Hong Kong
eTheRNA immunotherapies NV, a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and infectious diseases, announced the opening of its new subsidiary, eTheRNA Asia Limited (‘eTheRNA Asia’), with offices located in the Sheung Wan area of Hong Kong. &nbs...
Read more
Gold and silver mining from Brussels urban sewage
Researchers from the VUB and ULB have succeeded in extracting gold, silver and other precious materials from the Brussels sewage water. With the SUBLIMUS project they are looking for a way to do this on a large scale. The project is coordinated by Dr.
Read more
New open access cleanroom for microfabrication of microfluidic devices in glass and silicon
MICROLAB: VUB launching a new open access cleanroom for microfabrication of microfluidic devices in glass and silicon Microfluidics is a recent multidisciplinary scientific field concerned with the study and manipulation of fluids in channels smaller than 1 mm.
Read more
Innovative VUB spin-offs in healthcare are thriving
August brought us exciting news from 3 VUB spin-offs: eTheRNA, Fertiga and Precirix . They are active in the health sector and develop life-changing innovations in fertility and for the treatment of cancer & infectious diseases. Read more
Read more
Results of the survey on valorisation for Social Sciences, Humanities & the Arts
VUB TechTransfer helps researchers to valorise scientific research results and continuously strives to connect the university’s research-expertise with industry and society.
Read more
Precirix and IFE sign clinical trial manufacturing agreement
VUB spin-off Precirix , a clinical-stage biotechnology company developing novel radiopharmaceuticals in oncology, and the Institute for Energy Technology (IFE), a manufacturer of radiopharmaceutical products based in Norway, announced an agreement for the supply of Precirix’ radiopharmace...
Read more
Follow us on LinkedIn
VUB TechTransfer has its own LinkedIn business page! Are you also on LinkedIn? Follow us for updates on VUB's innovative research, news from our spin-offs and collaboration opportunities. Follow us
Read more
COMBAT-project fights animal parasitic disease
CIRAD, as coordinator of a consortium of 21 partners of which the VUB, has launched a new project to combat animal trypanosomosis, a parasitic disease transmitted by biting flies, including the infamous tsetse. VUB researcher Stefan Magez of the Department of Bio-engineering Sciences Cellu...
Read more
New capital round values Collibra at $5 billion
VUB spin-off Collibra has raised $250M in a funding round led by Sequoia Capital. This makes Collibra the most valuable Belgian tech company. Collibra is an enterprising software company and a spin-off from the Laboratory for Semantic Technology and Applications Resea...
Read more
ERIS survey for researchers
Within TechTransfer, the ERIS team is responsible for assisting VUB's research community in their quest for European funding for applied research.
Read more